Capricor Therapeutics Aktie

26,70 EUR +0,15 EUR +0,57 %

15:47:18

STU

30,66 USD -0,47 USD -1,51 %

16:09:35

BTT

Capricor Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Marktkap.1,55 Mrd. EUR

Div. Rendite0,00%

WKNA2PLU4

ISINUS14070B3096

SymbolCAPR

Capricor Therapeutics Aktien News

Sortieren:Datum Meistgelesen

14.03.26finanzen.netCapricor Therapeutics: Quartalsergebnisse zum jüngsten Jahresviertel

11.03.26TraderFoxPivotal-Points

Capricor Therapeutics (CAPR) im Pivotal-Point-Check: FDA-Durchbruch bei Herzmuskel-Therapie entfacht Kursrallye - Das ist der Fahrplan zur Zulassung!

11.03.26finanzen.netAusblick: Capricor Therapeutics stellt Ergebnisse des abgelaufenen Quartals vor

WerbungCapricor Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

04.12.25TraderFoxKursziele

TOP-5-Kursziele der Analysten am 04.12.25

12.11.25finanzen.netCapricor Therapeutics stellte Quartalsergebnis zum abgelaufenen Jahresviertel vor

09.11.25finanzen.netAusblick: Capricor Therapeutics stellt Ergebnisse des abgelaufenen Quartals vor

15.09.25PR NewswireCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

13.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

08.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

04.09.25PR NewswireCAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit

02.09.25PR NewswireLevi & Korsinsky Notifies Shareholders of Capricor Therapeutics, Inc.(CAPR) of a Class Action Lawsuit and an Upcoming Deadline

02.09.25PR NewswireCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

27.08.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

22.08.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

21.08.25PR NewswireCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

18.08.25PR NewswireCapricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR

18.08.25PR NewswireCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

13.08.25finanzen.netCapricor Therapeutics stellte Ergebnisse des abgelaufenen Quartals vor

11.08.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

06.08.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

05.08.25PR NewswireCapricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR

05.08.25PR NewswireCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

31.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

31.07.25PR NewswireThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 15, 2025 in Capricor Therapeutics, Inc. Lawsuit - CAPR

28.07.25PR NewswireCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

27.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

22.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

21.07.25PR NewswireCAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

17.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

12.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

07.07.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

27.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

26.06.25TraderFoxKursziele

TOP-5-Kursziele der Analysten am 26.06.25

23.06.25TraderFoxTrading-Sektionen

Capricor Therapeutics (CAPR): H.C. Wainwright bestätigt Kaufempfehlung mit 805 % Kurspotenzial - Panikreaktion könnte Einstiegsgelegenheit bieten!

22.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

17.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

12.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

07.06.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

Capricor Therapeutics News

Capricor Therapeutics News: auf dieser Seite finden Sie alle Capricor Therapeutics News und Nachrichten zur Capricor Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Capricor Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Capricor Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.